Maddock R J, Carter C S, Blacker K H, Beitman B D, Krishnan K R, Jefferson J W, Lewis C P, Liebowitz M R
University of California, School of Medicine, Department of Psychiatry, Davis.
J Clin Psychiatry. 1993 Mar;54(3):88-95.
Many investigators have reported that panic disorder (PD) patients with comorbid major depression (MD) have more severe symptoms and a poorer response to treatment than patients with PD alone. It is not known if this is due to a distinct and more serious underlying disorder in these patients or simply a result of the simultaneous presence of the two disorders.
Nondepressed patients presenting for treatment of panic disorder with agoraphobia (PDA) were studied before treatment (N = 180) and after 4 weeks of treatment with adinazolam sustained release (N = 89) or placebo (N = 91). Twenty-nine percent (N = 53) of the patients had a past history of MD. Symptom severity and treatment outcome were compared in patients with primary, secondary, single, recurrent, or no past MD.
There were no consistent differences in symptom severity or treatment outcome in patients with a past history of primary, secondary, or single episode MD compared with patients with no history of MD. However, a small number of patients with history of recurrent MD exhibited consistently greater symptom severity and poorer response to treatment than patients with no history of MD.
The greater severity and worse outcome of comorbid PD and MD observed in earlier studies are more likely due to the simultaneous presence of the two disorders than to a more serious and enduring underlying disorder. However, our results suggest that recurrent MD may indicate a more serious condition in patients with PDA. This possibility warrants further study.
许多研究者报告称,患有共病重度抑郁症(MD)的惊恐障碍(PD)患者比单纯患有PD的患者症状更严重,对治疗的反应更差。尚不清楚这是由于这些患者存在独特且更严重的潜在疾病,还是仅仅是两种疾病同时存在的结果。
对前来治疗伴有广场恐惧症的惊恐障碍(PDA)的非抑郁患者在治疗前(N = 180)以及接受阿地唑仑缓释片治疗4周后(N = 89)或接受安慰剂治疗4周后(N = 91)进行研究。29%(N = 53)的患者有MD病史。比较了有原发性、继发性、单次发作、复发性MD病史或无MD病史患者的症状严重程度和治疗结果。
与无MD病史的患者相比,有原发性、继发性或单次发作MD病史的患者在症状严重程度或治疗结果方面没有一致的差异。然而,少数有复发性MD病史的患者与无MD病史的患者相比,始终表现出更严重的症状和对治疗更差的反应。
早期研究中观察到的共病PD和MD更严重的症状及更差的结果,更可能是由于两种疾病同时存在,而非更严重且持久的潜在疾病。然而,我们的结果表明,复发性MD可能表明PDA患者的病情更严重。这种可能性值得进一步研究。